Dr. Nayef Antar Abouzaki, MD

Dr. Abouzaki practices at Chippenham Hospital in Richmond, Virginia, part of HCA Healthcare.

Dr. Abouzaki's NPI, 1164742359, was assigned on June 10, 2010. Dr. Abouzaki graduated from Eastern Virginia Medical School in 2010. Dr. Abouzaki holds Virginia license 0101251528.

Dr. Abouzaki's primary practice is Chippenham Hospital, at 7101 Jahnke Road, Richmond, VA 23225 in Richmond City. The practice phone is (804) 483-0000.

Dr. Abouzaki's primary practice is Chippenham Hospital in Richmond, Virginia, part of HCA Healthcare. Dr. Abouzaki is also affiliated with Henrico Doctors' Hospital. The medical group on file is Virginia Cardiovascular Specialists. Dmand AI also links Dr. Abouzaki to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abouzaki practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Abouzaki's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Abouzaki is licensed in Virginia.

CMS data shows 8,797 Medicare services from Dr. Abouzaki across 39 procedure codes in 2024, for 1,110 Medicare patients. Medicare paid $579,345 for them.

CMS counts 1,110 Medicare patients who saw Dr. Abouzaki in 2024. The largest group is 75 to 84, with 470 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Abouzaki's median patient age at 72, with 46% women.

In 2024, Dr. Abouzaki wrote 6,368 Medicare Part D claims for 736 patients. 76% of them were for generic drugs. CMS names the drug for 6,029 of them, across 49 drugs with 11 or more claims each, at $1,605,510 in total drug cost. In 2023, CMS named 4,286 claims across 41 drugs.

Dr. Abouzaki accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 54 procedures of coronary angioplasty and stenting by Dr. Abouzaki, more than 86% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Dr. Abouzaki, published from 2013 to 2025. 2014 was the busiest year, with 7. The most frequent topics are Interleukin 1 Receptor Antagonist Protein, Heart Failure and Double-Blind Method. Dr. Abouzaki has published most often in Am J Cardiol. Dr. Abouzaki's most frequent co-authors are Antonio Abbate, MD, Michael Lucas Gambill, DO and Dinesh Kadariya, MD.

CMS Open Payments shows 266 general payments to Dr. Abouzaki from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Abbott Laboratories paid the most, $2,928.

Dr. Abouzaki graduated from Eastern Virginia Medical School in 2010.